Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Diffusion Pharmaceuticals Inc (DFFN)

Diffusion Pharmaceuticals Inc (DFFN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,118
  • Shares Outstanding, K 63,998
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,800 K
  • 60-Month Beta 1.27
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.55
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.77
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/09/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.06
  • Prior Year -0.60
  • Growth Rate Est. (year over year) +91.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7500 +9.24%
on 09/08/20
1.0200 -19.68%
on 09/15/20
-0.1707 (-17.24%)
since 08/28/20
3-Month
0.7500 +9.24%
on 09/08/20
1.6000 -48.79%
on 07/21/20
-0.1761 (-17.69%)
since 06/26/20
52-Week
0.2110 +288.29%
on 11/18/19
1.9700 -58.41%
on 10/16/19
-1.1607 (-58.62%)
since 09/27/19

Most Recent Stories

More News
Diffusion Pharmaceuticals Strengthens Management Team with Appointment of William Elder as General Counsel and Corporate Secretary

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) ("Diffusion" or "the Company") today announced the appointment of William Elder, J.D., to the position of general counsel and corporate secretary, effective...

DFFN : 0.8193 (-1.29%)
Diffusion Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) ("Diffusion" or "the Company"), today announced its management will present at the H.C. Wainwright 22nd Annual Global Investment Conference to be held virtually...

DFFN : 0.8193 (-1.29%)
Five Pharmaceutical Stocks Investors May Want to Keep an Eye On

"Glioblastoma is the most common and aggressive cancerous brain tumour in adults due to its resistance ...

ABBV : 87.28 (+1.22%)
IMAB : 39.00 (+2.04%)
DFFN : 0.8193 (-1.29%)
AZN : 54.75 (-1.37%)
CLVS : 6.03 (+2.47%)
WBIO.CN : 0.290 (+5.45%)
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) ("Diffusion" or "the Company"), today announced that Robert ("Bob") J. Cobuzzi Jr., Ph.D., who has served as a member of the Company's Board of Directors since...

DFFN : 0.8193 (-1.29%)
ENDP : 3.20 (-2.29%)
Thinking about buying stock in Diffusion Pharmaceuticals, Zuora Inc, Walmart, Nio, or Dynatrace?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DFFN, ZUO, WMT, NIO, and DT.

DT : 40.82 (-0.87%)
DFFN : 0.8193 (-1.29%)
NIO : 18.81 (+2.67%)
WMT : 137.25 (-0.01%)
Diffusion Pharmaceuticals Appoints Jane H. Hollingsworth to its Board of Directors

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) ("Diffusion" or "the Company"), a biotechnology company developing new treatments for life-threatening medical conditions by improving the body's ability to...

DFFN : 0.8193 (-1.29%)
Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) ("Diffusion" or "the Company"), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body's...

DFFN : 0.8193 (-1.29%)
Diffusion Pharmaceuticals Files Clinical Trial Application for European Phase 1a/1b Study of TSC in COVID-19 Patients

Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) ("Diffusion" or "Company") announces the submission of a Clinical Trial Application (CTA) to the Romanian National Agency for Medicines and Medical Devices...

DFFN : 0.8193 (-1.29%)
Diffusion Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement

Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) ("Diffusion" or "the Company") announces that on May 29, 2020 it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market...

DFFN : 0.8193 (-1.29%)
Thinking about buying stock in Diffusion Pharmaceuticals, Remark Holdings, Spirit Airlines, Aurora Cannabis, or Century Casinos?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DFFN, MARK, SAVE, ACB, and CNTY.

ACB : 4.78 (-5.35%)
ACB.TO : 6.50 (-4.13%)
DFFN : 0.8193 (-1.29%)
SAVE : 16.53 (+2.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade DFFN with:

Business Summary

Diffusion Pharmaceuticals Inc. is a biotechnology company. Its product pipeline includes Trans Sodium Crocetinate, Glioblastoma Program, Pancreatic Cancer Program and Brain Metastases Program. The Company is focused on cancer treatments, such as radiation therapy and chemotherapy in treatment-resistant...

See More

Key Turning Points

2nd Resistance Point 0.8531
1st Resistance Point 0.8362
Last Price 0.8193
1st Support Level 0.7962
2nd Support Level 0.7731

See More

52-Week High 1.9700
Fibonacci 61.8% 1.2981
Fibonacci 50% 1.0905
Fibonacci 38.2% 0.8829
Last Price 0.8193
52-Week Low 0.2110

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar